Roche: Key data will be presented at the 2026 European Society of Medical Oncology Annual Meeting to show the progress of its advanced lung cancer and breast cancer pipeline combination.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.